SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lauren M. Pachman, Neuromuscular Disorders of Infancy, Childhood, and Adolescence, 2015,

    CrossRef

  2. 2
    Patricia López, Javier Rodríguez-Carrio, Ana Suárez, Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: Implication for systemic lupus erythematosus, Cytokine, 2014, 67, 1, 13

    CrossRef

  3. 3
    Yue-Bei Luo, Frank L. Mastaglia, Dermatomyositis, polymyositis and immune-mediated necrotising myopathies, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014,

    CrossRef

  4. 4
    Thorsten Hornung, Joerg Wenzel, Innate Immune-Response Mechanisms in Dermatomyositis: An Update on Pathogenesis, Diagnosis and Treatment, Drugs, 2014, 74, 9, 981

    CrossRef

  5. 5
    Floranne C. Ernste, Ann M. Reed, Recent advances in juvenile idiopathic inflammatory myopathies, Current Opinion in Rheumatology, 2014, 26, 6, 671

    CrossRef

  6. 6
    Imelda Balboni, Timothy B. Niewold, Gabrielle Morgan, Cindy Limb, Maija-Leena Eloranta, Lars Rönnblom, Paul J. Utz, Lauren M. Pachman, Brief Report: Interferon-α Induction and Detection of Anti-Ro, Anti-La, Anti-Sm, and Anti-RNP Autoantibodies by Autoantigen Microarray Analysis in Juvenile Dermatomyositis, Arthritis & Rheumatism, 2013, 65, 9
  7. 7
    Travis B. Kinder, Sree Rayavarapu, Kathryn White, Kanneboyina Nagaraju, Pathogenesis of myositis: Lessons learned from animal studies, Indian Journal of Rheumatology, 2013, 8, 4, 170

    CrossRef

  8. 8
    Pierre Quartier, Romain K. Gherardi, Pediatric Neurology Part III, 2013,

    CrossRef

  9. 9
    Ann M. Reed, Erik Peterson, Hatice Bilgic, Steven R. Ytterberg, Shreyasee Amin, Molly S. Hein, Cynthia S. Crowson, Floranne Ernste, Emily Baechler Gillespie, Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course, Arthritis & Rheumatism, 2012, 64, 12
  10. 10
    Yelena Koldobskaya, Kichul Ko, Akaash A. Kumar, Sandra Agik, Jasmine Arrington, Silvia N. Kariuki, Beverly S. Franek, Marissa Kumabe, Tammy O. Utset, Meenakshi Jolly, Andrew D. Skol, Timothy B. Niewold, Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  11. 11
    Corinna Preuße, Hans H. Goebel, Josephin Held, Oliver Wengert, Franziska Scheibe, Kerstin Irlbacher, Arend Koch, Frank L. Heppner, Werner Stenzel, Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile, The American Journal of Pathology, 2012, 181, 6, 2161

    CrossRef

  12. You have free access to this content12
    R. Goldbach-Mansky, Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1, Clinical & Experimental Immunology, 2012, 167, 3
  13. 13
    Tokunori Ikeda, En Kimura, Teruyuki Hirano, Makoto Uchino, The association between dermatomyositis and papillary thyroid cancer: a case report, Rheumatology International, 2012, 32, 4, 959

    CrossRef

  14. 14
    Xuan Feng, Nicholas P. Reder, Mounica Yanamandala, Addie Hill, Beverly S. Franek, Timothy B. Niewold, Anthony T. Reder, Adil Javed, Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis, Journal of the Neurological Sciences, 2012, 313, 1-2, 48

    CrossRef

  15. 15
    Anthony A. Amato, John T. Kissel, Swaiman's Pediatric Neurology, 2012,

    CrossRef

  16. 16
    Timothy B. Niewold, Interferon Alpha as a Primary Pathogenic Factor in Human Lupus, Journal of Interferon & Cytokine Research, 2011, 31, 12, 887

    CrossRef

  17. 17
    Michelle Batthish, Brian M. Feldman, Juvenile Dermatomyositis, Current Rheumatology Reports, 2011, 13, 3, 216

    CrossRef

  18. 18
    Yvonne E. Chiu, Dominic O. Co, Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use, Pediatric Dermatology, 2011, 28, 4
  19. 19
    Lily Kao, Lorinda Chung, David F. Fiorentino, Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon, Current Rheumatology Reports, 2011, 13, 3, 225

    CrossRef

  20. 20
    Corinna E. Weckerle, Timothy B. Niewold, The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies, Clinical Reviews in Allergy & Immunology, 2011, 40, 1, 42

    CrossRef

  21. 21
    Emily C Baechler, Hatice Bilgic, Ann M Reed, Type I interferon pathway in adult and juvenile dermatomyositis, Arthritis Research & Therapy, 2011, 13, 6, 249

    CrossRef

  22. 22
    Lisa G. Rider, Carol B. Lindsley, James T. Cassidy, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  23. 23
    Timothy B. Niewold, Silvia N. Kariuki, Gabrielle A. Morgan, Sheela Shrestha, Lauren M. Pachman, Gene-Gene-Sex Interaction in Cytokine Gene Polymorphisms Revealed by Serum Interferon Alpha Phenotype in Juvenile Dermatomyositis, The Journal of Pediatrics, 2010, 157, 4, 653

    CrossRef

  24. 24
    Sahil Khanna, Ann M. Reed, Immunopathogenesis of juvenile dermatomyositis, Muscle & Nerve, 2010, 41, 5
  25. 25
    Sheela Shrestha, Barry Wershil, John F. Sarwark, Timothy B. Niewold, Teresa Philipp, Lauren M. Pachman, Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells, Arthritis & Rheumatism, 2010, 62, 9
  26. 26
    Kelly A. Rouster-Stevens, Gabrielle A. Morgan, Deli Wang, Lauren M. Pachman, Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositis, Arthritis Care & Research, 2010, 62, 10
  27. 27
    Silvia N. Kariuki, Beverly S. Franek, Rachel A. Mikolaitis, Tammy O. Utset, Meenakshi Jolly, Andrew D. Skol, Timothy B. Niewold, Promoter Variant ofPIK3C3Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients, Journal of Biomedicine and Biotechnology, 2010, 2010, 1

    CrossRef

  28. 28
    Steven A Greenberg, Type 1 interferons and myositis, Arthritis Research & Therapy, 2010, 12, Suppl 1, S4

    CrossRef

  29. 29
    Silvano Sozzani, Type I interferons in systemic autoimmunity, Autoimmunity, 2010, 43, 3, 196

    CrossRef

  30. 30
    Martin Aringer, Mary K Crow, Josef S Smolen, Clinical applications of IFN-α blockade in systemic lupus erythematosus, International Journal of Clinical Rheumatology, 2009, 4, 6, 617

    CrossRef

  31. 31
    Boel De Paepe, Kim K Creus, Jan L De Bleecker, Role of cytokines and chemokines in idiopathic inflammatory myopathies, Current Opinion in Rheumatology, 2009, 21, 6, 610

    CrossRef